<DOC>
	<DOC>NCT02956642</DOC>
	<brief_summary>This study is a two-arm randomized controlled trial in which participants will receive either the Livongo Health system or iHealth glucose meter for measuring their blood glucose. The study hypothesizes the use of the Livongo Health system results in a greater improvement in A1c compared to standard blood glucose monitoring, as demonstrated by the iHealth Bluetooth-enabled glucose meter.</brief_summary>
	<brief_title>Study of Unprecedented Glucose Analysis and Results</brief_title>
	<detailed_description>Participants in this study will partake in study surveys, daily blood glucose monitor measurements, and blood sampling for the duration of their participation. The study intends to recruit and randomize 200 participants.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>People with type 1 or 2 diabetes mellitus on any type of medication Adults, age 18 years or older Not using continuous glucose monitoring or an insulin pump iOS Smartphone with access to data and/or WiFi Using continuous glucose monitoring during the study period Using an insulin pump during the study period Unable or unwilling to switch blood glucose meters to the study meter Hospitalization for DKA or hypoglycemia in the past 1 month prior to enrollment Pregnant patients, or intention to become pregnant during the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>